Etanercept improves linear growth and bone mass acquisition in MTX-resistant polyarticular-course juvenile idiopathic arthritis
99.09.01
|
Clinical analysis of systemic lupus erythematosus with gastrointestinal manifestations
99.8.1
|
High-Dose Cyclophosphamide Versus Monthly Intravenous Cyclophosphamide for Systemic Lupus Erythematosus
99.05.15
|
Effector and regulatory B cells: modulators of CD4+ T cell immunity
99.4.29
|
Study of Subcutaneous Fat in Children With Juvenile Dermatomyositis
99.04.15
|
Clinical Immunology Review Series:An approach to the patient with
recurrent orogenital ulceration, including Behcet’s syndrome
99.03.15
|
Age at Time of Corticosteroid Administration Is a Risk Factor for Osteonecrosis in Pediatric Patients With Systemic Lupus Erythematosus
99.02.09
|
Macrophage Activation Syndrome in Juvenile Systemic Lupus Erythematosus: A multinational multicenter study of thirty-eight patients
99.01.26
|
Interferon- mediates suppression of
C-reactive protein: Explanation for muted C-reactive protein response in lupus
flares?
99.01.06
|
Recurrence Rates of Cardiac Manifestations Associated With Neonatal Lupus and Maternal/Fetal Risk Factors
99.01.06
|
Extracorporeal shockwave for hip necrosis in
systemic lupus erythematosus 98.11.05
|
Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic
epidermal necrolysis
98.10.15
|
Rituximab in systemic lupus erythematosus A
systematic review of off-label use in 188 cases 98.09.22
|
Treatment of Kawasaki Disease: Analysis of 27 US
Pediatric Hospitals From 2001 to 2006
98.9.20
|
The Myeloid-Related Proteins 8 and 14
Complex, a Novel Ligand of Toll-Like Receptor 4, and Interleukin-1β
Form a Positive Feedback Mechanism in Systemic-Onset Juvenile Idiopathic
Arthritis 98.04.30
|
Ultrasonographic Evaluation of Cervical Lymph Nodes
in Kawasaki Disease
97.12.15
|
What
is the difference between IgA nephropathy and Henoch-Schonlein purpura?
|
Bone
Marrow Histological Findings in Systemic Lupus Erythematosus with Hematologic
Abnormalities: A
Clinicopathological Study
|
Common
Variable Immunodeficiency in Systemic Lupus Erythematosus
|
Kikuchi–Fujimoto Disease: analysis of 244 cases
|
Rituximab Therapy for Child-hood Onset Systemic
Lupus Erythematosus
|
Treatment of Severe Immune Thrombocytopenia Associated with Systemic Lupus
Erythematosus: 59 Cases
|
Subclinical
Atherosclerosis, but Normal Autonomic Function after Kawasaki Disease
|
Long-term
Survival of Southern Chinese Patients With Systemic Lupus Erythematosus A
Prospective Study
of All Age-Groups
|
TPMT
(1) Azathioprine: current status and future considerations
(2) Azathioprine in dermatology: The past, the present, and the future
|
Riruximab
therapy and B cell reconstitution
|
Septic
Arthritis in Patients with Systemic Lupus Erythematosus: Salmonella and
Nonsalmonella Infections
Compared
|
Hemolytic-uremic
syndrome in patients with systemic lupus erythematosus
|
Disease
duration, hypertension and medication requirements are associated with organ
damage in childhood-onset systemic
lupus erythematosus
|
Pulmonary hemorrhage in patients with systemic lupus erythematosus – review of case series
|
Systemic
lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors
predictive of new or worsening proteinuria
|